Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2013; 31:(3)433-423

Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020; 323:(19)1945-1960

Boehncke WH, Schön MP. Psoriasis. Lancet. 2015; 386:(9997)983-994

Brenaut E, Horreau C, Pouplard C Alcohol consumption and psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013; 27:30-35

Gisondi P, Sala F, Alessandrini F Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis. Dermatology. 2014; 228:(1)78-85

Lebwohl M. Vitamin D and topical therapy. Cutis. 2002; 70:5-8

Menon K, Van Voorhees AS, Bebo BF Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010; 62:(2)291-9

Menter A, Strober BE, Kaplan DH Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019; 80:(4)1029-1072

Menter A, Gelfand JM, Connor C Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol. 2020; 82:(6)1445-1486

Naldi L, Addis A, Chimenti S Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project. Dermatology. 2008; 217:(4)365-73

National Institute for Health and Care Excellence. Psoriasis: assessment and management. Clinical guideline CG153. 2017. (accessed 16 May 2023)

National Psoriasis Foundation. Causes and triggers. 2022a. (accessed 16 May 2023)

National Psoriasis Foundation. Inverse psoriasis. 2022b. (accessed 16 May 2023)

National Psoriasis Foundation. Guttate psoriasis. 2022c. (accessed 16 May 2023)

NHS website. Psoriasis. Treatment. 2022a. (accessed 16 May 2023)

NHS website. Psoriasis. Symptoms. Common types of psoriasis. 2022b. (accessed 16 May 2023)

Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019; 20:(6)

Psoriasis: overview, treatments and implications for nursing care

25 May 2023
Volume 32 · Issue 10

Psoriasis is a chronic, immune-mediated dermatological condition (Boehncke and Schön, 2015), affecting approximately 2% of the UK's population (NHS website, 2022a). The disorder typically presents as flaking skin patches that evolve into scales, exhibiting diverse appearances based on an individual's skin tone. Although psoriasis may cause minor irritation for some people, it can significantly impact others' quality of life, particularly those experiencing severe manifestations.

This article offers an analysis of psoriasis in the nursing context, encompassing risk factors, aetiology, pathophysiology, clinical classification, causative factors, triggers, diagnosis, treatment, and nursing considerations for patients living with the condition.

Psoriasis is a complex disease with numerous risk factors and a multifactorial inheritance pattern. Approximately one-third of affected patients have a first-degree relative with the disorder, suggesting a hereditary predisposition (NHS website, 2022a). Genome-wide association studies have discovered several genetic loci related to psoriasis susceptibility; however, the exact mechanisms through which these genetic factors contribute to the condition's development remain to be elucidated (Rendon and Schäkel, 2019).

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content